Elicio Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Elicio Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Elicio Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.64 USD/shares, a 75.5% increase year-over-year.
  • Elicio Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was 18.6 USD/shares.
  • Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -6.96 USD/shares, a 92.2% increase from 2022.
  • Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -89.3 USD/shares, a 4525% decline from 2021.
  • Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.93 USD/shares, a 64.5% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7 +$82.30 +92.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$89 -$87 -4525% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$2 +$3.50 +64.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 -$5 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.